Anavex Life Sciences Corp. (AVXL)
1.19
-0.11
(-8.46%)
USD |
NASDAQ |
Oct 30, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Cash and Short Term Investments (Annual) : 102.58M for Sept. 30, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 102.58M |
| September 30, 2024 | 132.19M |
| September 30, 2023 | 151.02M |
| September 30, 2022 | 149.16M |
| September 30, 2021 | 152.11M |
| September 30, 2020 | 29.25M |
| September 30, 2019 | 22.19M |
| September 30, 2018 | 22.93M |
| September 30, 2017 | 27.44M |
| September 30, 2016 | 9.187M |
| September 30, 2015 | 15.29M |
| Date | Value |
|---|---|
| September 30, 2014 | 7.262M |
| September 30, 2013 | 0.3451M |
| September 30, 2012 | 0.0114M |
| September 30, 2011 | 0.1347M |
| September 30, 2010 | 0.2647M |
| September 30, 2009 | 0.351M |
| September 30, 2008 | 0.0064M |
| September 30, 2007 | 0.00 |
| September 30, 2006 | 0.0123M |
| September 30, 2005 | 0.001M |
| September 30, 2004 | 0.0281M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Vaxcyte, Inc. | 1.561B |
| Foghorn Therapeutics, Inc. | 160.14M |
| Connect Biopharma Holdings Ltd. | 44.34M |
| Caribou Biosciences, Inc. | 139.34M |
| Arrowhead Pharmaceuticals, Inc. | 919.37M |